International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals Ltd has achieved a significant milestone with the United States Food & Drug Administration's approval for their generic version of Sumatriptan injection, used in combating ...

A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...

Aug 5 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India.

Alembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets, used for treating seizures and nerve pain. The approval covers 100 mg, 200 mg ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections PIVYA expected to be available in the U.S. in the 4th ...